Vis enkel innførsel

dc.contributor.authorvan Wamel, Annemieke
dc.contributor.authorHealey, Andrew
dc.contributor.authorSontum, Per C.
dc.contributor.authorKvåle, Svein
dc.contributor.authorBush, Nigel
dc.contributor.authorBamber, Jeffrey
dc.contributor.authorDavies, Ruth Catharina de Lange
dc.date.accessioned2017-10-20T11:04:46Z
dc.date.available2017-10-20T11:04:46Z
dc.date.created2016-05-18T13:49:21Z
dc.date.issued2016
dc.identifier.citationJournal of Controlled Release. 2016, 224 158-164.nb_NO
dc.identifier.issn0168-3659
dc.identifier.urihttp://hdl.handle.net/11250/2461254
dc.description.abstractProof of principle for local drug delivery with Acoustic Cluster Therapy (ACT) was demonstrated in a human prostate adenocarcinoma growing in athymic mice, using near infrared (NIR) dyes as model molecules. A dispersion of negatively charged microbubble/positively charged microdroplet clusters are injected i.v., activated within the target pathology by diagnostic ultrasound (US), undergo an ensuing liquid-to-gas phase shift and transiently deposit 20–30 μm large bubbles in the microvasculature, occluding blood flow for ~ 5–10 min. Further application of low frequency US induces biomechanical effects that increase the vascular permeability, leading to a locally enhanced extravasation of components from the vascular compartment (e.g., released or co-administered drugs). Results demonstrated deposition of activated bubbles in tumor vasculature. Following ACT treatment, a significant and tumor specific increase in the uptake of a co-administered macromolecular NIR dye was shown. In addition, ACT compound loaded with a lipophilic NIR dye to the microdroplet component was shown to facilitate local release and tumor specific uptake. Whereas the mechanisms behind the observed increased and tumor specific uptake are not fully elucidated, it is demonstrated that the ACT concept can be applied as a versatile technique for targeted drug delivery.nb_NO
dc.language.isoengnb_NO
dc.publisherElseviernb_NO
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleAcoustic Cluster Therapy (ACT) - pre-clinical proof of principle for local drug delivery and enhanced uptake.nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber158-164nb_NO
dc.source.volume224nb_NO
dc.source.journalJournal of Controlled Releasenb_NO
dc.identifier.doi10.1016/j.jconrel.2016.01.023
dc.identifier.cristin1356060
dc.relation.projectNorges forskningsråd: 2228604nb_NO
dc.description.localcode© 2016. This is the authors’ accepted and refereed manuscript to the article. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/nb_NO
cristin.unitcode194,66,20,0
cristin.unitnameInstitutt for fysikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal